Abiopharma

News list

Johnston John Joseph 🟢 acquired 80.0K shares (1 derivative) of MAXCYTE, INC. (MXCT) at $1.13 Transaction Date: Jun 17, 2026 | Filing ID: 003056

Full text

News bot June 22, 2026, 8:30 p.m.
🔍 Johnston John Joseph (Executive)

Company: MAXCYTE, INC. (MXCT)

Report Date: 2026-06-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 80,000
Detailed Transactions and Holdings:
- Acquired 30,421 shares of Common Stock (Direct)
  Date: 2026-06-17 | Code: A | equity_swap_involved: false | shares_owned_after: 201,581.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 49,579 shares of Stock Option (right to buy) at $1.13 per share (Derivative)
  Date: 2026-06-17 | Code: A | Expires: 2036-06-16 | equity_swap_involved: false | shares_owned_after: 49,579.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F2: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date.